Mangalam Organic
Mangalam Organic Q3 FY26 investor presentation: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.
Mangalam Organic Q3 FY26 key numbers
- Revenue
- Revenue growth for FY25 was Rs. 530.01 Cr, a 7.39% increase over FY24 (Rs. 493.52 Cr).
As stated in Mangalam Organic's Q3 FY26 investor presentation · published 16 Oct 2026. Reported figures, not investment advice.
Based on Mangalam Organic's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3 FY26 revenue from operations: Rs. Q3 FY26 EBITDA: Rs.
From Mangalam Organic's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Q3 FY26 revenue from operations: Rs. 164.29 Cr, a 32.58% increase YoY over Q3 FY25's Rs. 123.92 Cr (Pages 16, 17, 18).
- EBITDA for Q3 FY26: Rs. 19.3 Cr, up 22.85% YoY (Page 17).
- PAT for Q3 FY26: Rs. 4.34 Cr, up 19.56% YoY (Page 17).
- Revenue growth for FY25 was Rs. 530.01 Cr, a 7.39% increase over FY24 (Rs. 493.52 Cr) (Page 15).
2 more points from Mangalam Organic's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mangalam Organic said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Fundraising & Capital Structure
See what Mangalam Organic said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Mangalam Organic said on order book & pipeline — free account, 30 seconds.
Mangalam Organic — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹164 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mangalam Organics Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio Solutions Ltd (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mangalam Organic and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mangalam Organic Q3 FY26 results?
Q3 FY26 revenue from operations: Rs. Q3 FY26 EBITDA: Rs.
What is Mangalam Organic share price analysis?
Mangalam Organic currently shows a neutral. The stock trades at a P/E of 16.0 with a market cap of ₹376 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mangalam Organic planning capital expenditure?
The presentation mentions capital work-in-progress amounts increasing from Rs.
Keep Mangalam Organic on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
